Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cann Group ( (AU:CAN) ).
Cann Group Limited has applied to the ASX for quotation of 13,163,102 new fully paid ordinary shares, with an issue date of 1 May 2026. The additional securities, arising from the exercise or conversion of existing options or other convertible instruments, will expand the company’s quoted share capital and may influence its capital structure and trading liquidity once admitted to quotation.
The move reflects the company’s ongoing use of equity-linked instruments to fund operations or incentivise stakeholders, consolidating these into ordinary stock on the market. For existing shareholders, the enlarged pool of quoted shares may have dilution implications but could also support improved market depth and facilitate future capital-raising flexibility as Cann Group advances its medicinal cannabis activities.
More about Cann Group
Cann Group Limited is an Australian-listed company in the medicinal cannabis sector. The group focuses on cultivating, producing and supplying cannabis-based products, serving domestic and potentially export pharmaceutical and therapeutic markets under the ticker CAN on the ASX.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.87M
See more data about CAN stock on TipRanks’ Stock Analysis page.